Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
J Lipid Res ; 51(6): 1591-8, 2010 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-20093478

RESUMEN

The aim of the study was to develop a method for fast and reliable diagnosis of peroxisomal diseases and to facilitate differential diagnosis of cholestatic hepatopathy. For the quantification of bile acids and their conjugates as well as C(27) precursors di- and trihydroxycholestanoic acid (DHCA, THCA), in small pediatric blood samples we combined HPLC separation on a reverse-phase C18 column with ESI-MS/MS analysis in the negative ion mode. Analysis was done with good precision (CV 3,7%-11.1%) and sufficient sensitivity (LOQ: 11-91 nmol/L) without derivatization. Complete analysis of 17 free and conjugated bile acids from dried blood spots and 10 microL serum samples, respectively, was performed within 12 min. Measurement of conjugated primary bile acids plus DHCA and THCA as well as ursodeoxycholic acid was done in 4.5 min. In blood spots of healthy newborns, conjugated primary bile acids were found in the range of 0.01 to 2.01 micromol/L. Concentrations of C(27) precursors were below the detection limit in normal controls. DHCA and THCA were specifically elevated in cases of peroxysomal defects and one Zellweger patient.


Asunto(s)
Ácidos y Sales Biliares/sangre , Ácidos y Sales Biliares/química , Análisis Químico de la Sangre/métodos , Recolección de Muestras de Sangre , Carbono/química , Suero/química , Atresia Biliar/sangre , Cromatografía Liquida , Galactosemias/sangre , Humanos , Lactante , Recién Nacido , Modelos Lineales , Trastorno Peroxisomal/sangre , Espectrometría de Masas en Tándem , Factores de Tiempo , Ácido Ursodesoxicólico/uso terapéutico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA